Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
Diabetes Prevention Program Research Group; Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. Diabetes Prevention Program Research Group, et al. Among authors: hamman rf. Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29. Lancet. 2009. PMID: 19878986 Free PMC article. Clinical Trial.
The diabetes prevention program and its global implications.
Molitch ME, Fujimoto W, Hamman RF, Knowler WC; Diabetes Prevention Program Research Group. Molitch ME, et al. Among authors: hamman rf. J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S103-7. doi: 10.1097/01.asn.0000070140.62190.97. J Am Soc Nephrol. 2003. PMID: 12819312 Free PMC article. Clinical Trial.
Achieving weight and activity goals among diabetes prevention program lifestyle participants.
Wing RR, Hamman RF, Bray GA, Delahanty L, Edelstein SL, Hill JO, Horton ES, Hoskin MA, Kriska A, Lachin J, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner JG, Venditti B, Wylie-Rosett J; Diabetes Prevention Program Research Group. Wing RR, et al. Among authors: hamman rf. Obes Res. 2004 Sep;12(9):1426-34. doi: 10.1038/oby.2004.179. Obes Res. 2004. PMID: 15483207 Free PMC article. Clinical Trial.
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group. Herman WH, et al. Among authors: hamman rf. Ann Intern Med. 2005 Mar 1;142(5):323-32. doi: 10.7326/0003-4819-142-5-200503010-00007. Ann Intern Med. 2005. PMID: 15738451 Free PMC article.
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
Knowler WC, Hamman RF, Edelstein SL, Barrett-Connor E, Ehrmann DA, Walker EA, Fowler SE, Nathan DM, Kahn SE; Diabetes Prevention Program Research Group. Knowler WC, et al. Among authors: hamman rf. Diabetes. 2005 Apr;54(4):1150-6. doi: 10.2337/diabetes.54.4.1150. Diabetes. 2005. PMID: 15793255 Free PMC article. Clinical Trial.
Managing people at high risk for diabetes.
Herman WH, Hoerger TJ, Hicks K, Brandle M, Sorensen SW, Zhang P, Engelgau MM, Hamman RF, Marrero DG, Ackermann RT, Ratner RE. Herman WH, et al. Among authors: hamman rf. Ann Intern Med. 2006 Jan 3;144(1):66-7; author reply 67-8. doi: 10.7326/0003-4819-144-1-200601030-00018. Ann Intern Med. 2006. PMID: 16389262 No abstract available.
Physical activity in individuals at risk for diabetes: Diabetes Prevention Program.
Kriska AM, Edelstein SL, Hamman RF, Otto A, Bray GA, Mayer-Davis EJ, Wing RR, Horton ES, Haffner SM, Regensteiner JG. Kriska AM, et al. Among authors: hamman rf. Med Sci Sports Exerc. 2006 May;38(5):826-32. doi: 10.1249/01.mss.0000218138.91812.f9. Med Sci Sports Exerc. 2006. PMID: 16672833 Free PMC article. Clinical Trial.
Effect of weight loss with lifestyle intervention on risk of diabetes.
Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner J, Venditti B, Wylie-Rosett J. Hamman RF, et al. Diabetes Care. 2006 Sep;29(9):2102-7. doi: 10.2337/dc06-0560. Diabetes Care. 2006. PMID: 16936160 Free PMC article. Clinical Trial.
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group. Florez JC, et al. Among authors: hamman rf. J Clin Endocrinol Metab. 2007 Apr;92(4):1502-9. doi: 10.1210/jc.2006-2275. Epub 2007 Jan 9. J Clin Endocrinol Metab. 2007. PMID: 17213274 Free PMC article. Clinical Trial.
331 results